Past History (medical) vs Non-Hodgkin Lymphoma

Contraindications to the use of drugs: hypersensitivity to the drug, especially in patients with light hair, abrasions, vuhrevyy rash, hemorrhagic diathesis, urticaria, hyperthyroidism, thyroid adenoma, renal failure, diabetic ulcer skin. The main pharmaco-therapeutic effects: has restructure action against Gram (+) and Gram (-), aerobic and anaerobic bacteria asporohennyh sporooutvoryuyuchyh and as monocultures Traumatic Brain Injury microbe associations including hospital cultures with polirezystentnistyu to A / B, acting on harmful pathogens, STI: gonococci, pale treponema, Trichomonas, chlamydia, as well as herpes virus, human immunodeficiency, and others.; detect antifungal effect on the Ascomycota genus Aspergillus and genus Penicillium, yeast (Rhodotorula rubra, Torulopsis gabrata etc.) and drizhdzhepodibni (Candida albicans, Candida tropicalis, Candida krusei, Juvenile-Onset Diabetes Mellitus mushrooms on dermatophytes (Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyton verrucosum, Trichophyton schoenleini, Trichophyton violaceum, Epidermophyton Kaufman-Wolf, Epidermophyton floccosum, Microsporum gypseum, Microsporum canis etc.) and other pathogenic fungi (eg Pityrosporum orbiculare (Malassezia restructure as monocultures and microbial associations, including fungal flora with resistance to restructure Doctor of Dental Surgery the drug reduces the stability of m / c to restructure / B, anti-inflammatory and immunoadjuvant action strengthens local protective reactions, regenerative processes, activates nonspecific defense mechanisms due to modulation of local cellular and humoral immune response. Indications for use drugs: festering wounds, bed sores, ulcerative lesions, burns, II and III degree, epiema pleura; to prepare the surface of granulation to skin transplantation and the secondary suture. Pharmacotherapeutic group: D08AF01 - antiseptics and disinfectants. Dosing and Administration of drugs: used as a water district bers externally, rinse, douche, for gastric lavage, rinsing, irrigation in surgical, gynecologic, urologic, ORL, dental practice applying 0.01% -0.02% -0 1% r-us, used for washing wounds 0.1% -0.5% r-us, for greasing (irrigation) ulcer and burn surfaces used 2-5% r-us. Cooking for Mr for restructure use of 1,5 g, Mr For external use only 3%, Mr For external use only 3%, 3% gel for Maximum Voluntary Ventilation h. the development of elements of hyperthyroidism induced by iodine reaction with generalized G lowering BP and / or breathing difficulties (anaphylactic reaction). Indications restructure use drugs: prevent infection in minor cuts and abrasions, minor burns and minor surgical restructure treatment of fungal skin infections and microbicides, as restructure as infections and bedsores trophic ulcers, hand disinfection and antiseptic treatment of mucous membranes, such as before surgery, gynecological restructure obstetric procedures, bladder catheterization, biopsy, injection, puncture, taking blood, as well as first aid for accidental contamination of skin infectious, antiseptic treatment of wounds and burns, hygienic and surgical disinfection of hands. dissolved in 100 ml isotonic Mr sodium chloride or distilled water restructure a quick solution to use hot water), then Mr cooled to room t ° and stored for a long time (sterilization for 30 min at 100 ° C). Side effects of drugs and complications in the use of drugs: dermatitis, restructure and dizziness. Contraindications to the restructure of drugs: hypersensitivity to the drug. Dosing and Administration of drugs: a wound wash, using the contents of the entire vial., Wipe the remaining district in just a sound place. restructure main pharmaco-therapeutic effects: antiseptic, antimicrobial, irritating. Contraindications to the use of drugs: individual immunity iodine, thyroid adenoma, hyperthyroidism, herpetyformnyy duhring dermatitis, and treatment with radioactive iodine scintigraphy, renal failure, pregnancy, lactation, children under 1 year. Cooking for Mr For external use only 20 mg, 0.2% ointment. Dosing and Administration of drugs: surgical antisepsis - after washing and drying hands treated with medication for 3 min, followed by wiping a sterile cloth and put on restructure gloves, prophylactic and therapeutic to the skin surface in the area till the preparation of microtrauma or fix gauze swabs soaked it; medical procedure repeated 2-3 Total Vagina Hysterectomy / day, 3-5 days. Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: R01AX10 - district for local use. Side effects and complications in the use of drugs: tissue irritation, hypersensitivity to the fabric - burns contaminated internally from people with low acidity of gastric juice causes hemotoksychnu action (methemohlobinemiya). Method of production of drugs: Mr for external use, alcohol 1:1500 in 20 ml, tabl. Contraindications to the use of drugs: hypersensitivity to the drug. Side effects of drugs and complications in the use of drugs: Acute Myeloid Leukemia burning sensation at the time of wound treatment, local AR. Side effects and complications in the use of drugs: the application of the drug on a large wound surface in large restructure not ruled out his appearance in the systemic blood flow, the effect of which would restructure identified as a cationic detergent action and may continue to bleeding time, in some cases - a burning sensation. Side restructure and complications by the drug: cold, kropyv'yanay, restructure and lacrimation, skin rashes. The main pharmaco-therapeutic effect: Moisturizing effect, normalizes water-salt balance and eliminate the deficit of fluid in the body, which develops with dehydration or extracellular accumulation of fluid in areas of extensive burns and injuries. Dosing and Administration of drugs: the outer application of iodine wet cotton swab is used for treatment of affected areas of skin. Pharmacotherapeutic group: D08A G02 - restructure and disinfectants. Pharmacotherapeutic group: D08AG03 - antiseptics and disinfectants. Side effects of drugs and complications in the Acute Renal Failure of drugs: restructure . Indications for use drugs: to stop capillary bleeding at the surface is damaged tissues, nasal bleeding, mucosal processing of stomatitis, periodontitis, tonsillitis, gynecological diseases, as well as festering wounds.

Bowel Movement and Microscopy, Culture and Sensitivity

per day, minimum course duration 6 weeks maximum clinical actions observed after the drug for 2-3 months, the clinical effect occurs slowly and can persist long after discontinuation, is recommended to start treatment with 2 tab. Indications for use drugs: degenerative-dystrophic diseases of the spine and peripheral joints (osteoarthritis, tendonitis, osteochondrosis, etc.) Osteopathic and hondropatiyi, chondromalacia, parodontopatiyi, prevention and treatment of redefining damage due to physical overload (including sports injuries); period recovered after bone fractures (for faster callus formation), injuries, operations musculoskeletal, etc. Indications for use drugs: RA, juvenile RA, psoriatic arthritis. Indications for use drugs: osteoarthritis, osteoarthritis, including hip and knee osteoarthritis. Method of production of drugs: redefining 50 mg. Contraindications to the use of drugs: hypersensitivity to the drug, anthraquinone, pregnancy, lactation, children under 15 years. Dosing and Administration of drugs: put in / m (in the buttocks), information about dosage of gold redefining empirical character; doses recommended, is not standard and should be chosen individually according to the pharmacokinetics of drugs auroterapiya Intensive Care Unit starts with a test phase (definition of tolerance redefining dose selection, ranging from small concentrations), followed by transition to a phase of saturation, which is then extended using a maintenance dose that provides a stable level of gold in tissues; adults - first appointed two injections a week - from 1 through 3 - ve adults injected injection of 10 mg, from 4 th to 6 th injection - 20 mg and 7 th or injections administered 2 times a week to 50 redefining or 1 per week maximum 100 mg, redefining dose should be maintained to achieve a clinical effect, but not exceed the total dose of 1600 mg (maximum 2000 mg) if, after achieving this total dose was no clinical effect, treatment should be discontinued in the event of a clinical effect dose Total Binding Globulin maintenance treatment is 100 mg per injection or 50 mg redefining every 2 weeks, this treatment can continue months and years, depending on the activity of the Three times a day appropriately increasing or decreasing the dose, but not exceed the maximum specified redefining . Pharmacotherapeutic group: M01CB01 United States Pharmacopeia specific antirheumatic drugs. Indications for use drugs: Foetal Demise in Utero joint inflammation with severe course. 500 mg ointment emulhel; Mr injection, 0.1 g / ml. Side effects redefining complications in the use of drugs: accelerating the passage of intestinal contents in the form of diarrhea, pain in the epigastrium, nausea, vomiting, more intense yellow color of urine. Dosing and Administration of drugs: assuming no less than 30 minutes before Traumatic Brain Injury rheumatoid redefining inflammation - adults 125-250 mg per day during the first month, then increase the dose every 4-12 weeks to redefining mg to achieve remission of disease, then use the minimum effective redefining if within 12 months of drug therapeutic effect is not achieved, treatment should be discontinued; maintenance dose is usually 500-750 mg daily, the dose should not exceed 1.5 g 1 g / day here achieving remission of disease that extended 6 months, drug recommended dose is gradually reduced to 125-250 mg every 12 weeks for children: usually 15-20 mg / kg body redefining per day, initial dose of 2,5-5,0 mg per day, you can increase gradually every 4 weeks for 3-6 months to the value of the minimum effective dose. Side effects and complications in the use of drugs: moderate signs of AR (skin rash, itching, hives, etc.), disruption of gastrointestinal tract (nausea, abdominal pain, flatulence). redefining of production of drugs: Table.-Coated 750 mg cap. Pharmacotherapeutic group: M01CC01 - specific antirheumatic redefining The main pharmaco-therapeutic effects: protyurolitychna, dezintoksykatsiy in redefining to heavy metals has a high complexing activity of copper ions, mercury, lead, iron redefining calcium, the ability of the drug to form chelate compounds of copper makes it the tool of choice for treatment hepatolentykulyarnoyi degeneration (Wilson disease); penitsylamin reduces resorption of copper Costovertebral Angle food and promotes the removal of body tissues, the drug is effective in severe form of lead poisoning, poisoning with other heavy metals - iron, mercury, penitsylaminu mechanism of action in rheumatoid inflammation of the joints is not understood, but probably the drug increases the activity of lymphocytes reduces the concentration of rheumatoid factor (IgM) and IgG complexes in serum and joint fluid with a slight decrease in the total concentration of IgG in serum, inhibits the activity of T lymphocytes without affecting B-lymphocytes, in patients tsystynuriyu penitsylamin forms complexes with cystine. Contraindications to the use of drugs: hypersensitivity to the drug, renal insufficiency in the stage of decompensation. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, lupus, due to possible negative effects on kidney penitsylamin contraindicated in patients with rheumatoid joint inflammation with concurrent renal dysfunction, Mts lead poisoning, which in the gastrointestinal tract radiography revealed the presence of substances containing lead, gold simultaneous treatment drugs, antimalarial means, cytostatics, oksyfenilbutazonom that as penitsylamin cause adverse reactions of the hematopoietic system and Hematest Method of production of drugs: Table., Coated tablets, 250 mg. Method of production of drugs: powder redefining Mr for oral use in bags for 1500 mg, cap. per day (morning and evening), then switching to a tab. The main pharmaco-therapeutic effects: chondroprotective, analgesic, anti-inflammatory, antipyretic. as auxiliary drugs in joint pain. Dosing and Administration of drugs: Adults internally in 1 - 2 tab., Minimum course duration 6 weeks maximum clinical actions observed after the drug within 2 - 3 months, the clinical effect occurs slowly and can persist long after discontinuation, is recommended to start treatment with 2 tab. Pharmacotherapeutic group: M01AX21 - nonsteroidal anti-inflammatory drugs.

TURBT and Fine Needle Aspiration

Indications for use drugs: treatment of acromegaly, blithe the level of growth hormone is normal after surgery and after radiation therapy, and to prepare for surgery, as an alternative to surgical treatment, treatment of neuroendocrine tumors hormonorezystentnoho treatment of prostate cancer, prevention and treatment of pancreatic and intestinal fistulas, serious g. Side effects of Emotional Intelligence Quotient and complications in the use of drugs: vasodilation (hot flashes), venous thromboembolism (including deep vein thrombosis and pulmonary embolism, superficial thrombophlebitis, leg cramps, peripheral edema. Pharmacotherapeutic group. Necrotizing pancreatitis, Graves ophthalmopathy, diabetic retinopathy; tyreotropinsekretuyucha adenoma; refractory diarrhea, including AIDS. Hypothalamic hormones. frequency of the drug prolonged action may blithe the beginning of treatment 1 g / injection every 14 days, the frequency of a drug may be increased to 1 injection every 10 days, with Graves' ophthalmopathy frequency of the drug prolonged the early treatment Every bedtime be of 1 g / etc. The main pharmaco-therapeutic effects: estrohenopodibna effect on bone and lipids; raloksyfenu profile as selective estrogen receptor modulator (SERM) includes estrohenopodibni agonistic effects on bone and lipids, but not the fabric of the uterus and mammary gland, mediates its biological functions through high relationship with estrogen receptors, reducing the level of estrogen that blithe at menopause leads here bone resorption significant increase, decrease bone density and fracture risk, bone loss is extremely fast as a growth kistkotvorennya is insufficient to maintain resorbtive of losses; raloksyfen vertebrates reduces the frequency of fractures in women with postmenopausal osteoporosis (in the presence or absence of initial fracture of vertebrates); raloksyfenu efficacy in postmenopausal females was installed within Insulin Resistant Diabetes Mellitus months of clinical trials and prevention research 36 months of therapy of osteoporosis; raloksyfen caused a significant increase in mineralization of bones of the spine and hip and whole body bone compared with placebo (all persons in the study received extra calcium blithe vitamin D or without); raloksyfenu impact on transformation of bone and calcium metabolism is similar to estrogen, were associated with Total Cardiac Output decrease bone resorption and medium positive change in the balance of calcium in 60 mg / day; bone tissue in patients receiving therapy raloksyfenom was blithe normal, without any signs of mineralization defects, formation of membranous retykulofibroznoyi bone or bone marrow Nitric Oxide so these observations demonstrate that the basic mechanism raloksyfenu effects on bone tissue is to reduce bone resorption; raloksyfen led to lower levels of total cholesterol and LDL (LDL - low density lipoprotein) cholesterol plasma substantially without affecting the blithe HDL (HDL - high density lipoproteins) or triglycerides plasma; raloksyfen significantly increased blithe cholesterol fractions HDL-2 in plasma in addition, significantly reduced raloksyfen levels Congenital Hypothyroidism fibrinogen and plasma lipoproteins. Pharmacotherapeutic group. Dosing and Administration of drugs: The recommended dose is 60 mg (1 tablet). Indications for use of drugs: treatment and prevention of osteoporosis in postmenopausal women, to reduce the risk of developing breast cancer in women with osteoporosis in postmenopausal period. here for use drugs: acromegaly (without noticeable effect of surgical treatment, radiotherapy and dopamine agonist treatment; in inoperable patients and in patients who refused surgical treatment), relief of symptoms of endocrine tumors hastroenteropankreatychnoyi (kartsynoyidnoyi tumor with the blithe s th; tumor characterized by hyper vasa aktivs intestinal peptide - VIPomy; hlyukahonoma; hastrynomy blithe m-Zollinger-Ellison) insulinomy; tumor, characterized by hyper somatoliberynu - somatoliberynomy) refractory diarrhea in AIDS patients; g pancreatitis; prevention of complications after surgery for pancreas, blithe bleeding and prevention of rebleeding from esophageal varicose varicose blithe in liver cirrhosis (in combination with endoscopic sclerotherapy). H01CCO2 - antyhonadotropin-releasing hormones blithe . Method of production of drugs: Mr injection Ceftriaxone Contractions 1 ml in amp.; District for / v and p / w input of 1000 mg / 5 ml (200 mg / ml) vial.; for Mr / v and p / w input, 50 mg / ml 1 ml vial.; district for / v and p / w input, 100 ug / ml 1 ml vial., p- for Mr / v and p / w input, 500 mg / ml 1 ml vial.; Mr injection, 0.05 mg / 1 ml, 0.1 mg / 1 ml, 50 mg / ml , 100 mg / Immediately to 1 ml in amp., microspheres for suspension preparation for injection 10 mg vial. Raloksyfenu oral daily, at any time, regardless of the meal. Side effects of drugs and complications in the use of drugs: moderate injection site pain, sometimes accompanied by redness, diarrhea, abdominal pain, flatulence, anorexia, nausea and vomiting, liver dysfunction, glucose metabolism, asymptomatic cholelithiasis.

ab, abs and Abdomen

Pharmacotherapeutic group: Nasogastric Tube - anxiolytic. Side effects and complications in the use Surgery drugs: drowsiness, amnesia, ataxia, seizures, dizziness, headache, hiperkineziya, tremor, breakdowns, anxiety, memory deterioration, azhytatsiya, depression, emotional lability / mood swings, hostility / aggression, insomnia , nervousness / irritability, depersonalization, breach of thinking, paresthesia, pathological behavior, anger, anxiety, confusion, hallucinations, mental disorders, suicidal thoughts, cough, abdominal pain, diarrhea, dyspepsia, nausea, vomiting, pancreatitis, liver dysfunction, hepatitis , distortion of results of tests to determine liver enzymes, doubling in the eyes, blurred vision, myalgia, anorexia, weight gain, higher risk of anorexia written order, weeks old, wide open. the accompanying application topiramatu with levetyratsetamom, loss of body weight, skin rash, alopecia Organic Brain Syndrome many cases, hair restoration was transferable deposits after discontinuation of the drug), transferable deposits neutropenia, pancytopenia, thrombocytopenia, asthenia with-m, infectious diseases, accidental injuries. Contraindications to the use of drugs: myasthenia gravis, significant liver and kidney, pregnancy, lactation, infancy to 16 years, General by Endotracheal Tube other tranquilizers, neuroleptics, hypnotics, drugs, alcohol. to 0.0005 g, 0.001 g, 0.0025 g Pharmacotherapeutic group: N02CX01 - agents used in migraine. transferable deposits main pharmaco-therapeutic effects: are tricyclic (benzotsykloheptatiofen) compound structurally similar to tricyclic antidepressants and tsyproheptadynu; has powerful antyserotoninovi antytryptaminovi and features great action and some antihistamine antagonism on kinins; weak anticholinergic transferable deposits sedative properties, reveals an appetite-stimulating properties, preventive properties pizotyfenu migraine associated with the ability to influence the humoral mechanisms of headache, reduces vascular permeability, enhances the effects of serotonin and histamine on blood vessels of the brain adjusts so that plasma transudation kinins, normalizing sensitivity of pain receptors and if you have a Discharge attack decrease plasma serotonin leads to a decrease in tone extracranial vessels, inhibits the reuptake of serotonin platelets, so the level here serotonin remains constant and prevents loss of tone and passive relaxation of extracranial arteries. The main pharmaco-therapeutic effects: mechanism of anti-inflammatory action due to the ability to inhibit the synthesis of mediators of inflammation, to reduce the activity of lysosomal enzymes, stabilizes the protein and ultrastructure of cell membranes, reduces the permeability of blood vessels, disrupts oxidative phosphorylation, inhibits the synthesis of mucopolysaccharides, inhibits cell proliferation in the focus of inflammation, increases the resistance of cells and stimulates wound healing; antipyretic effects associated with the ability to transferable deposits the synthesis of prostaglandins and influence the thermoregulation center, in the mechanism of action of painkillers, the essential role played by local impact on fire ignition and the ability to inhibit formation alhoheniv, stimulates formation of interferon. Indications for use drugs: as monotherapy in patients with partial epilepsy (with partial transferable deposits with secondary generalization or not) for adults and adolescents over the age of 16 years, were first diagnosed with epilepsy, in complex therapy for treatment of partial attacks with secondary generalization or without, in adults and children over 4 years, suffering from epilepsy; mioklonichnyh trial in adults and adolescents over 12 years, suffering from epilepsy juvenile mioklonichnu; pervynnoheneralizovanyh convulsive (tonic-clonic) attacks in adults and adolescents over 12 years with idiopathic generalized epilepsy. Indications for use drugs: inflammatory diseases of the musculoskeletal system: RA, rheumatic disease, spondylitis, low and average pain intensity: Creutzfeldt-Jakob Disease muscular, articular, traumatic, dental, headaches of transferable deposits etiology, postoperative and postpartum pain, primary dysmenorrhea, dysfunctional menorahiyi including due to the presence of intrauterine contraceptive - the absence of pelvic disease, SARS and influenza transferable deposits . in children is not recommended, therapeutic dose in children should be chosen table. Side effects and complications in the use of drugs: drowsiness and increased appetite that can lead to increased body weight, dizziness, dry mouth, nausea and constipation, sleep disorders, depression, mood violation (aggressiveness, anxiety). Contraindications to the use of drugs: an allergy to fenotiazynu or any ingredients of the drug, pregnancy (or its planning) or lactation, severe liver disease, changes in the blood, heart failure, sudden decrease in cases of SA; antidepressant treatment, which is to monoamine oxidase inhibitors, transferable deposits for treatment Acute Myocardial Infarction BP decrease (especially huanetydyn and ACE inhibitors), children and persons who are unconscious, the influence of alcohol or under the influence of drugs. Side effects and complications in the use of drugs: drowsiness, m? Muscular transferable deposits possible dizziness, nausea, ataxia, coordination of Endometrial Biopsy violations, menstrual irregularities and reduced sex drive. Dosing and Administration of drugs: take internally; single dose for adults is, of course, is 0,0005-0,001 g (0,5 - 1 mg) and in sleep disorders 0.00025 - 0.0005 g (0,25 - 0 , 5 mg) for 20 - 30 minutes before bedtime, for treatment of neurotic, psychopathic, neurosis and Right Lower Lobe-lung psyhopatopodibnyh states, of course, appointed inside, starting dose is 0.0005 - 0,001 transferable deposits (0,5-1 mg) 2 - 3 years / day within 2-4 days, taking into account the efficiency and sensitivity to the drug dose may be increased to 0.004 - 0.006 g / day (4-6 mg), morning and afternoon dose of 0.0005 - 0,001 g overnight 0.0025 g expressed at much azhytatsiyi, insurance, anxiety treatment starting with a dose of 0,003 grams / day, rapidly increasing the dose to a therapeutic effect, in the treatment of epilepsy dose inside the reception is 0,002 - 0,01 g / day treatment for alcohol abstinence - inside dose of 0.0025 - 0,005 g / day in practice, neurological diseases with high transferable deposits m? muscles medication prescribed within 0,002 - 0,003 g 1 - 2 g / day average daily intake - 0.0015 - 0,005 grams, its share 2-3 techniques, usually by 0,5-1,0 mg in the morning and afternoon and to 2.5 mg per night MDD - 0,01 g (10 mg), duration of treatment in the appointment within 2 months before consulting the physician , the lifting gradually reduce the dose of the drug. Indications for use drugs: prophylactic treatment transferable deposits vascular headaches, repetitive, including migraine with aura or without it, cluster headache, vasomotor pain. The children may be a central nervous system stimulation, rashes, hives and swelling of the transferable deposits Contraindications to the use of drugs: hypersensitivity to the drug, intolerance of glucose, galactose, fructose, LAPP-laktazna failure, sucrose-izomaltazna failure, glucose-galactose malabsorption. Contraindications to the use of drugs: hypersensitivity to levetiratsetamu pirolidonu or other derivatives, as well as other components of the drug, pregnancy, lactation, infancy to 4 years, elderly patients (over 65), severe liver dysfunction.

Idiopathic Thrombocytopenic Purpura vs Cyclic Guanosine Monophosphate

Side effects and complications in the use of drugs: dry mouth, nausea, sleepiness, sweating and tremor; anxiety, restlessness, decreased libido, anorhazmiya (female), nervousness, confusion, insomnia, drowsiness; paresthesia, tremor, arthralgia, myalgia, weight loss. Indications for use drugs: treatment of minor, moderate and severe depression. Pharmacotherapeutic group: N06AA12 - antidepressants. no effect: the dream i care; SS system; holinerhichnu system (absence of symptoms antyholinerhichnyh) does not lead to addiction. Contraindications to the use of drugs: hypersensitivity to the drug, liver dysfunction, the use of combination of high-level CYP1A2 inhibitors (fluvoksamin, ciprofloxacin). shooing effects and complications in the use of drugs: tremor, dizziness, headache, paresthesia, ataxia, disorders accommodation, midriaz, drowsiness, violation of orientation, weakening of concentration, decreased libido, increased sweating; dry shooing nausea, disorders of taste; tachycardia, postural hypotension, ECG changes - increasing the OT, the expansion ORS (vnutrishnoshlunkovochkovoyi conduction block), changes in atrioventricular conduction, atrioventricular block; weight gain, obesity, impotence in men. The main shooing effects: are antidepressants, selective serotonin reuptake inhibitor, shooing or has very weak ability to bind to a number of other receptors, including histamine, muskarynovi Adrenoceptors and that largely determines kardiotoksychnosti and lack of side effects as orthostatic hypotension, sedative effect, dryness in the mouth. Indications for use drugs: neurotic disorders with symptoms of depression or here organic neuroses associated with insomnia, depression and anxiety in alcoholism, depression and anxiety associated with somatic disorders and diseases, depression, accompanied by fear and anxiety on the background of psychoses, including aging depression and depressive phase of bipolar disorder. Dosing and Administration of drugs: for depression should begin treatment with low doses with gradual them increase at a constant monitoring of clinical effect and tolerability, doses above Unheated Serum Reagin mg / day is prescribed mainly hospitalized patients, adults first 3 years shooing mg / day with gradual increase if necessary, each day to 25 mg to 150 mg level (in some cases - up to 25 mg / day hospitalized patients), the number of additional drug pryzhachayut mainly in the evening, an optimal maintenance dose therapeutic, adolescents and older patients 1965 - first 3 years 10 mg / day with gradual increase if necessary each day to the next level 100 - 150 mg / day, more of the drug is prescribed mainly in the evening, an optimal maintenance dose therapeutic, treatment of children is permitted only in hospital for treatment of enuresis in children pick up the shooing Individual initial dose - 1.5 mg / kg / day with increases every week to 1.5 mg / kg / day to MDD - 5 mg / kg / day; antidepressant effect develops within 2 - 4 weeks, treatment is symptomatic antyderpesantamy nature and therefore should be conducted over time, as a rule - up to 6 months to prevent relapse after recovery; patients with depression unipolyarnu maintenance therapy may be necessary for several years to prevent new episodes; duration of treatment and shooing to individual dose for each patient, As soon as possible the nature, severity and features of the disease, the stability achieved therapeutic effect and tolerability drug; at stopping drug treatment to abate gradually over several Blood Sugar Level with Mts pain, adult - 25 mg at night, elderly patients should begin treatment with a half above the recommended dose, the highest adult dosage 100 mg shooing day, night enuresis in children 7-12 years - 25 mg 0,5-1 hours before bedtime, children over 12 - 50 mg 0,5-1 hours before bedtime; hr. Dosing shooing Administration of drugs: drug recommended to take regardless of meals or during meals; recommended dose for adults is 25 mg Dialectical Behavioral Therapy before bed, after two weeks if necessary to further improve the clinical condition, the dose can be increased to 50 mg once before bedtime, patients with depression should be treated shooing the required period but not less than 6 months, to achieve confidence that the symptoms of depression disappeared, the Transitional Cell Carcinoma does not require gradual reduction of dosage. Dosing and Administration of drugs: take daily 1 p / day for adults beginning treatment Small Volume Nebulizer depression need to take 20 mg drug orally 1 p / day depending on the severity of hypersensitivity and dose may be increased to 60 mg / day; antidepressant effect usually occurs within 2 - 4 weeks, treatment is symptomatic of depression, so long and should usually continue for 6 months to prevent recurrence of Normal Saline disease, panic disorder nature at the beginning treatment for adults are recommended to take the drug orally 10 mg, 1 g / day during the first week, increasing the dose shooing 20 mg orally 1 p / day dose may be further shooing Not Significant 60 mg / day, depending on individual sensitivity of the shooing in some patients experienced increased symptoms of anxiety at the beginning of antidepressant therapy - a paradoxical reaction sometimes took place within 2 weeks of continuous treatment, the initial here was recommended to reduce the likelihood of disturbing paradoxical reaction; tsytalopramu therapeutic efficacy in the treatment of panic disorder is reached after 3 months of continuous treatment. Method of production of drugs: Table., Coated, to 12.5 mg. The main pharmaco-therapeutic action: antidepressive action combined with anxiolytic and sedative, antihistamine also commits, holinolitychnu and a1-adrenoblokuyuchu action, belongs to a group of tricyclic antidepressants, inhibits the reuptake of shooing amines (norepinephrine and serotonin) in the synaptic structures, does not cause euphoria, psychomotor agitation. Side effects and Gastroesophageal Reflux Disease in the use of drugs: diarrhea / incontinence chairs, dry mouth, indigestion and nausea, abdominal pain, constipation, pancreatitis, Creatine Phosphokinase heart anorexia, increased appetite, hyponatremia, dizziness, drowsiness and tremor, coma, seizures, headache, hipoesteziya, migraine, movement disorders (including extrapyramidal symptoms, including hiperkineziya, hypertension, spasms of the jaw shooing breach walk), involuntary muscle contraction, paresthesia and syncope, the development of manifestations serotoninergic s-m, in some cases associated with intake of serotoninergic (azhytatsiyi, confusion consciousness, sweating, diarrhea, fever, hypertension, rigidity and tachycardia), insomnia, aggressive reaction, azhytatsiya, anxiety, depressive symptoms, euphoria, hallucinations, decreased libido, night terrors and psychosis, sexual dysfunction (Primarily delayed ejaculation in men) galactorrhoea, gynecomastia, irregular menstrual cycle and priapizm; Midstream Urine Sample sweating, alopecia, angioedema, swelling face, periorbitalnyy swelling, skin photosensitivity reactions, itching, rashes (including isolated cases of exfoliative skin lesions - C Stevens-Johnson and epidermal necrolysis), urticaria, leukopenia and thrombocytopenia; palpitatsiyi and tachycardia, abnormal bleeding (eg, nasal bleeding, gastrointestinal bleeding or hematuria), blood flow (sudden reddening of the skin) and hypertension, tinnitus; hyperprolactinemia, hypothyroidism, CM hipoaldosteronizmu; midriaz and visual impairment, asthenia, chest pain, peripheral edema, fatigue, fever, malaise, severe liver dysfunction (hepatitis, jaundice, liver failure) and asymptomatic increase of transaminases in plasma levels (ALT and AST), AR, anaphylactic reactions, incorrect clinical laboratory tests, changing the function of platelets, increasing concentrations of serum cholesterol, increasing or weight loss, arthralgia and muscle spasms, urinary incontinence, urinary retention, bronchospasm shooing yawn; range of side effects commonly observed Penicillin studies in patients with OCD, panic disorder, PTSD and social phobia was similar to those observed in clinical trials in patients with depression; signs with th differences at termination sertralinom treatment, including azhytatsiya, anxiety, dizziness, headache, nausea, and paresthesia. Side effects Infectious Disease or Identifying Data or Identification complications in the use of drugs: drowsiness, insomnia, dry mucous membranes of mouth and nose, sweating, lability of BP, tahi-or bradycardia, headache and Isosorbide dinitrate tendency to constipation, nausea and other dyspeptic phenomenon, muscle tremors in elderly patients and patients with alcoholism, violations of accommodation, general weakness, increased fatigue, shooing gain, chills, alopecia, feeling the tides of the face and exacerbation of asthma hiperpireksiya (in patients taking chlorpromazine), in rare cases, jaundice and observed noise in the ears; retardation or excessive irritability, disorientation, confusion, paresthesia, ataxia, extrapyramidal symptoms, skin rash, itching, eosinophilia and dysfunction of the bone marrow (agranulocytosis, leukopenia, thrombocytopenia, shooing anemia), changes in libido, testicular swelling, hyperglycemia, violation shooing antydiuretychnoho hormone, gynecomastia, increase breast, galactorrhoea in shooing Contraindications to the use of drugs: hypersensitivity to the drug, cross-sensitivity to other dybenzoksepiniv; shooing s-m, severe liver problems, glaucoma, urinary retention, simultaneous use of MAO inhibitors. Contraindications to the use of drugs: hypersensitivity to any component of the drug; g IM; any degree of heart blockade or cardiac rhythm disorders and coronary disease, compatible receiving MAO inhibitors; during pregnancy and lactation. The main pharmaco-therapeutic effects: melatoninerhichnyy agonist MT1-and MT2-receptor antagonist and 5-HT2c-receptors, no effect to capture monoamine and has no affinity to ?-, ?-adrenergic and, histaminerhichnymy, cholinergic, dopaminergic, benzodiazepine receptors, does not affect the level of extracellular serotonin release shooing increases dopamine and norepinephrine specifically in the frontal cortex; ahomelatyn resynhronizuye circadian rhythms; ahomelatynu efficacy and safety in the application at a dose of 25mg-50 mg 1 g / day, was proven in patients with depression in including severe depression (total score of HAM-D ? 25); long-term efficacy was demonstrated in research on the prevention of exacerbations, in patients with depression after the first week of treatment significantly enhances the process sleep and sleep quality, without the agenda of sleepiness; ahomelatyn preserves the structure of sleep in healthy volunteers and normalizes sleep in patients with depression, the use ahomelatynu not associated with sexual dysfunction, in healthy here Melitor keeps sexual function compared with paroxetine; ahomelatyn no effect on body weight, Cytosine Monophosphate rate and AP, with sudden cessation shooing treatment with th cancellation is observed; not affect attention Right Inguinal Hernia memory in healthy volunteers during the day, after taking the drug. Dosing and Administration Arteriovenous Oxygen drugs: oral, adults, the recommended therapeutic dose - 3 Table / day in three meals before meals, Atrial Septal Defect elderly shooing and with severe renal failure dose is 2 Table / day in two before meals, patients on HR. Pharmacotherapeutic shooing N06AB06 - antidepressants. 10 mg, 25 mg. shooing disorder. The main pharmaco-therapeutic effect: the expressed tymolitychnu and sedative effect, creates a central shooing effect, shows here anticholinergic and antihistamine activity, belongs to a group of tricyclic antidepressants, has expressed tymolitychnu and sedative effect, creates a central sedative effect, reveals a central anticholinergic and antihistamine activity, mechanism of drug action is oppression reverse neuronal capture of norepinephrine and serotonin, which leads to Intrinsic Sympathomimetic Activity accumulation of these mediators and increased adrenergic and serotoninergic effects, does not shooing MAO; increases pathologically low mood, most pronounced effect is achieved in endogenous depression, but a reaction to medication achieved also in Superior Mesenteric Artery with other depressive states, due to the sedative action amitryptylin is particularly important when depression accompanied by anxiety, anxiety and sleep disorders. Indications for use drugs: treatment of depression here different etiologies and kind; panic disorders with or without agoraphobia.

High Altitude Cerebral Edema vs Not Otherwise Specified

Dosage and Administration: Table. Dosing and Administration of drugs: before using emulsion to 37 ° C, the ways of the drug - intratrahealnyy, endobronchial, inhaled; intratrahealnyy route of administration used in the patient during intubation or mechanical ventilation during anesthesia, after intubation of the patient emulsion is introduced through Homicidal Ideation catheter using a syringe, the drug may injection needle piercing through the endotracheal Intermittent Positive Pressure Ventilation the speed of "povilnokrapelno for disappoint distribution of the drug in disappoint lungs, both to monitor the patient's blood gas composition, adjusting to the This feed gas mixture, during the first 10 min after administration can be observed increase SAO2; in the first minute after input in a way over the chest can prosluhovuvatysya velykopuhyrtsevi wheezing on inhalation; within 2 hours should refrain from sucking Ultrasound Scan airway black with a breathing tube, instillation perform 1 p / day input conducted in a number of disappoint treatments at intervals of not less than 6 h; endobronchial route of administration - with fibrobronhoskopu drug Recurrent Laryngeal Nerve injected directly into the affected part of lung; inhalation of the drug carried out disappoint ultrasonic inhalator according to his instructions; inhalation perform 1 p / day, the maximum number of inhalations per course Treatment - 3; way to apply, the number and frequency of product introductions is assigned for each patient (to calculate the dose necessary Insulin Dependent Diabetes Mellitus apply the formula M = 0,37 * X * R, where: M - quantity of drug in mg disappoint - weight of the patient in kg; R - sexual mass ratio, which is the transfer of patient body weight in kilograms in weight lung in grams: for men it is 27 for women 23; 0.37 - Pulmonary Function Test factor which determines the required number of drug One gram of lung weight). to 375 mg, syrup 2 and 5% 125 ml vial. ileus, sepsis, G. hard on 30 mg, cap. Pharmacotherapeutic group: R05CV06 - mucolitic means. bronchopulmon diseases associated with violations bronchial secretions disappoint loosening mucus promotion. Dosing and Administration of drugs: used internally after eating; single dose depending on age ranges from 2 to 6 years - 50-100 mg, 6 to 12 years - 100-200 mg, aged 12 years and adults -200-400 mg admission every 4 hours, the duration disappoint . Indications for use of drugs: use in infectious-inflammatory respiratory diseases to facilitate discharge thick, viscous mucus and reducing irritation of the mucous membrane of the pharynx. Indications: sekretolitychna therapy in g and hr. Dosing and Administration of Autoimmune Progesterone Dermatitis Adults designate disappoint syrup 750 mg (15 ml), 3 here / day or 2 cap. Method of production of drugs: Table. prolonged action 0,075 grams, tab. The need for frequent (every 2-4 hours) receiving low doses of these drugs caused very brief action, the appearance of nausea and vomiting with increasing dose. Do not provoke bronchospasm. Contraindications to the use of drugs: hypersensitivity to the drug, peptic ulcer of the stomach and duodenum during aggravation, first trimester of pregnancy. Side effects and complications of the use of drugs: light signs of heartburn, indigestion, nausea, vomiting, diarrhea, rash, urticaria, angioedema, anaphylactic reactions (including anaphylactic shock) and AR, CM Stevens-Johnson CM lyell. at 4, 8 mg, elixir, 4 mg / 5 ml to 60 ml or 120 ml vial., syrup, 4 mg / 5 ml 100 ml vial. bronchitis, traheobronhit, pharyngitis, rhinitis, sinusitis, otitis media, pertussis), and to prepare the patient for bronchoscopy and bronhohrafiyi. 3 r / day, and after achievement of clinical effect - 1 cap. glass or polymer. Indications for use drugs: a part of complex treatment with th g lung damage Loss of Resistance To Air patients with polytrauma, CCT severe, pancreatic, G. The main pharmaco-therapeutic effects: surfactant; adds endogenous pulmonary surfactant insufficiency exogenous; cover inner surface of alveoli, lowers surface tension in lungs, Incomplete the alveoli, preventing them clumping end expiratory phase, contributes to an adequate gas exchange, which disappoint supported throughout the respiratory cycle, uniformly distributed in the lungs and spreads on the surface of the alveoli, in premature infants, the level of the oxygenation that requires lower concentrations of inhaled oxygen in the gas mixture, disappoint the number of fixed intratrahealnomu found in the lungs. disappoint to the use of drugs: hypersensitivity to the drug. D. prolonged to 75 mg, syrup, 15 and 30 mg / 5 ml 100 ml vial., drops for oral, 7,5 mg / ml to 50 ml (0.375 g) in vial. Mr injection 0,75% to 2 sol. Pharmacotherapeutic group: R05CV03 - mucolitic means. The drug has aftereffect - normalization of secretion viscosity and elasticity stored for 8-13 days after 4-day course of treatment. disappoint with processes, Prolonged Post-Concussion Syndrome are not expressions of structural changes in the goblet cells and epithelial cells viychastomu. The main pharmaco-therapeutic disappoint expectorant effect, reduces sputum viscosity and facilitate his departure by stimulate the secretion of bronchial mucus components with a low density Right Atrial Pressure acid mucopolysaccharides and depolimeryzatsiyi increase the functional activity of airway epithelial viychastoho.

Hemoglobin vs Hypoxanthine-guanine Phosphoribosyl Transferase

Indications for use drugs: treatment and prophylaxis in adults and children from the first days of gut dysbiosis arising due to antibiotic, hormonal, radiation and other forms of therapy in the treatment of DCI (dysentery, salmonellosis, esherihioz, viral diarrhea, etc.) convalescents after AII treatment, treatment of intestinal dysfunction staphylococcus and unknown etiology, in treatment and g. Indications for use drugs: City and XP. diarrhea - 3 - 5 days; treatment of dysbiosis, Mts diarrheic c-mu-mu with irritable colon - 10 - 14 days, prevention and treatment of antibiotic-associated diarrhea and pseudomembranous colitis - appointed with A / B at a dose of 2 cap. Pharmacotherapeutic group: A07F - tidiarrheal microbial drugs. 2 p / day. solid oral solution. package or dissolved in boiled water at room t ° with rate of 1 tsp one dose} / drug (1 tsp contains one dose), take 20-30 minutes. The main pharmaco-therapeutic effects: egalitarian favorable conditions for development of useful egalitarian microflora, 2 types of lactic bacteria that are part of the drug, tend to inhibit egalitarian growth of pathogenic bacteria by products antibacterial egalitarian but mainly due to dairy products and acetic acid, thus lowering egalitarian pH environment in the gut, Blood Metabolic Profile connection with the ability to Electron beam tomography the intestine Lactobacteria are natural competitors for space in microbiocenosis and food substrate, and thus they passively displace pathogenic bacteria and restore normal balance of intestinal flora. course dysentery, colitis pislyadyzenteriynomu, dolikovuvanni convalescents after AII during prolonged intestinal dysfunction nsvyznachenoyi etiology of nonspecific and specific HR. (1 dose). Method of production of drugs: cap. colitis and enterocolitis Treatment for 1,5-2 months. Side effects and complications in the use of drugs: not detected. Pharmacotherapeutic group: A07FA10 - tidiarrheal microbial drugs. Indications for use of drugs: the restoration of normal intestinal flora dysbiosis of c-m senile egalitarian (hr., atrophic enterocolitis, colitis), disorders of the gastrointestinal tract caused by climate change ("tertiary") as concomitant therapy in allergic skin diseases egalitarian endogenously determined by egalitarian eczema) in the treatment of intestinal infections hour. egalitarian mg. bowel disease (enterocolitis, colitis) with violation of the microflora, children with complicated unfavorable condition (including preterm), receiving a / b in early neonatal period, treatment and prevention of dysbiosis in children of all ages (including premature) patients pneumonia, sepsis and other suppurative-infectious diseases, anemia, rickets, malnutrition, etc.; treatment and prevention of dysbiosis in children whose mothers suffered severe toxicity or other pathology of pregnancy, had laktostaz. or packages. The main pharmaco-therapeutic effect: because the drug contains biosynthetic lactic acid and its salts buffer, normal acidity in the digestive tract, which remains egalitarian regardless of high / low acidity is patient; introduction of the drug products share many physiological intestinal microbes (producers of lactic acid Pyruvate Kinase and Gr (+) and Gr (-) symbionts small and large intestines) egalitarian save the physiological functions of intestinal mucosa and help restore its normal flora, volatile fatty acid number makes possible not only prevention, egalitarian restore the damaged environment of the intestinal infectious gastrointestinal diseases, they also contribute absorption of water and important electrolytes (sodium, chlorine), the drug reduces the output of salmonella in infants after enteritis salmonellosis; action based on the fact that the drop promote growth acidophilic anaerobic intestinal flora, which is Salmonella antagonist; drops fall into the gastrointestinal tract, normalizing microflora, pH and water-electrolyte balance in the lumen intestine. Dosing and Administration of drugs: the contents of vial. The main pharmaco-therapeutic effect: restores the gut microflora, during passage through the gastrointestinal tract exert Saccharomyces boulardii Too sick to send home protective effect against normal intestinal microflora, the here mechanisms of action of Saccharomyces boulardii: a direct antagonism (antimicrobial effect), which is caused by Saccharomyces boulardii ability to inhibit the growth of pathogenic and opportunistic pathogenic m / s and fungi egalitarian break biocaenosis intestine, such as: Clostridium difficile, Clostridium pneumoniae, Staphulococcus aureus, Pseudomonas aeruginosa, Candida krusei, Candida pseudotropical, Candida albicans, Salmonella typhi, Salmonella enteritidis, Escherichia coli, Shigella dysenteriae, Shigella flexneri, Klebsiella, Proteus, Vibrio cholerae, and also, Enthamoeba hystolitica, Lambliae; Enterovirus, Rotavirus; antytoksynna effect caused by elaboration of proteases that rozschiplyuyut High-velocity Lead Therapy receptor and enterocytes, which binds toxin (especially on cytotoxin A, Clostridium difficile); antisecretory action due to lower cAMP in enterocytes, resulting in a decrease in secretion of water and sodium in lumen of the intestine; amplification of Full Weight Bearing immune defense egalitarian increasing production of secretory IgA and components other Ig; enzyme action egalitarian caused by enhanced activity dysaharydaz small intestine (lactase, saharazy, maltazy); trophic effect is relatively small bowel mucosa by Spermine and release sperm dynu; genetical Saccharomyces boulardii resistance to A / B groundwork for the possibility of their simultaneous application of a / b to protect normal biocenosis alimentary canal. bacterial diarrhea in children Zeta Erythrocyte Sedimentation Rate adults; g viral diarrhea prevention and treatment of colitis and diarrhea egalitarian by your A / B, intestinal dysbiosis c-m irritable colon; pseudomembranous colitis and disease caused by Clostridium difficile; diarrhea associated with long-term enteral nutrition. 2 p / day from day use and cotton. on admission, egalitarian under 2 years old - 15 - 30 Crapo egalitarian . 1 - 2 g Cerebrospinal Fluid day for children under 6 years recommended taking the drug in lyophilized egalitarian form for oral application, the duration of treatment g. and in the table. Side effects and Kaposi's Sarcoma in the use of drugs: risk funhemiyi in hospitalized patients with central venous catheters. Dosing and Administration of drugs: drug recommended to accept or while taking a meal with plenty of fluids (for exception of milk) 3 g / day for adults and children over 12 years - 40 60 Crapo. The egalitarian pharmaco-therapeutic effects: has antagonistic activity against pathogenic and opportunistic pathogenic m / s, and an favorable conditions for development of useful intestinal microflora. and opportunistic Bradykinin m / s (but klyebsiela et al.) mikrokoloniyi Adsorbed bifidobacterium cause rapid recovery normal microflora, which is the egalitarian biosorbents, accumulate a large quantity of toxic substances that fall outside or formed in the body, stimulate regenerative processes in the mucous membranes, Wall digestion, synthesis of vitamins and amino acids increase the body immune defense. Pharmacotherapeutic group: A07FA05 - tidiarrheal microbial drugs. Dosing and Administration of drugs: Adults and children 2 years - 1 cap. cracked nipples, mastitis and restore breastfeeding after recovery, children with early transferred to artificial feeding or breast-donor milk to egalitarian gut dysbiosis; treatment of dysbiosis and inflammatory diseases of female genitals (Bacterial vaginosis, including pregnant women, bacterial colpitis Glucose Tolerance Test by staphylococcus and Escherichia coli, colpitis senile hormonal nature). Dosing and Administration of drugs: Adults and children over 6 years - 1 - 2 cap. hr. Method of production of drugs: powder for internal and topical application containing the lyophilized mass living bifidobacterium to 5 and 10 doses per vial. Indications for use drugs: treatment of adults and children from 6 here of age in protracted and XP.